A researcher applies phylogenetic approaches to study the origins of creationist legislation in the US.
Claire Pomeroy from the Albert and Mary Lasker Foundation writes that a 'culture shift' is needed to support women in science.
In Science this week: CRISPR as breakthrough of the year, and more.
Some pathogenic gene variants are only weakly linked to disease, writes Ed Yong at the Atlantic.
As part of wellness programs, companies are beginning to offer employees genetic testing.
In a tongue-in-cheek yet serious study, researchers report that men with moustaches outnumber women in leadership positions at US academic medical departments.
In Nature this week: bacterial diversity in the gut microbiomes, and more.
When eminent researchers in a scientific field die, space opens up for new ideas, according to a new analysis.
Robert Green writes at the Huffington Post that genomic sequencing might not disrupt medical practice, but rather give clinicians another tool to use.
In PLOS Medicine, investigators say that medical research isn't as diverse as it should be, and offer ways to address that gap.
In Cell this week: single-cell RNA sequencing study of immune cells, killifish genome characterization, and more.
The number of National Institutes of Health-funded clinical trials has dipped as the number funded by industry has risen, a trio of Johns Hopkins researchers says.
A GAO review finds no evidence of disparities in grant success rates by gender at agencies with sufficient data, but some agencies are not conducting required Title IX compliance reviews.
Lasker Award winner Evelyn Witkin discusses her career in a Q&A with the New York Times.
In PNAS this week: identification of human follicle mite lineages using mtDNA, copy number expansions in cattle NK-lysin gene, and more.
The changes that occur to the microbiome upon death may someday be harnessed as a forensic tool.
Cherry Murray has been confirmed as the new Department of Energy Office of Science head.
Researchers hope to again use DNA testing to confirm that Romanovs were killed during the Russian Revolution, NPR reports.
In PLOS this week: gene expression differences in plants susceptible to or resistant to Plum pox virus, novel human pegivirus, and more.
The Wall Street Journal looks into the debate over regulation of lab-developed tests.
The Woodrow Wilson International Center's Eleonore Pauwels and Jim Dratwa examine personalized medicine as a sort of Faustian bargain.
With a new collaboration with the Wallenberg Center for Protein Research, AstraZeneca is looking to the secretome, Reuters says.
In Science this week: earning outcomes for US PhD recipients, and more.
CNBC's Meg Tirrell says she's happy she got her genome sequenced, though she didn't make many changes to her life because of it.
The cells that make up tumors influence how they respond to treatment, suggesting that tumors need to be deeply sampled to develop personalized treatments.